Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News GenMark Diagnostics Inc. GNMK

GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary... see more

Recent & Breaking News (NDAQ:GNMK)

GenMark Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020

GlobeNewswire April 22, 2020

GenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue Guidance

GlobeNewswire April 7, 2020

GenMark Awarded BARDA Grant for the Development of ePlex® RP2 Panel

GlobeNewswire March 23, 2020

GenMark Receives FDA Emergency Use Authorization for its ePlex® SARS-CoV-2 Test

GlobeNewswire March 19, 2020

GenMark Diagnostics Announces Submission of Emergency Use Authorization for its ePlex® SARS-CoV-2 Test

GlobeNewswire March 11, 2020

GenMark Diagnostics Reports Fourth Quarter and Full Year 2019 Results

GlobeNewswire March 2, 2020

GenMark Diagnostics Announces Global Shipments of ePlex® RUO Test Kits Designed for SARS-CoV-2 Detection

GlobeNewswire March 2, 2020

GenMark Diagnostics to Participate in the Cowen Health Care Conference

GlobeNewswire February 18, 2020

GenMark Diagnostics Schedules Fourth Quarter and Full Year 2019 Financial Results Conference Call for March 2, 2020

GlobeNewswire February 10, 2020

GenMark Diagnostics Announces CEO and Chairman Transition

GlobeNewswire February 10, 2020

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2019

GlobeNewswire January 13, 2020

GenMark Diagnostics to Participate in the J.P. Morgan Healthcare Conference

GlobeNewswire December 30, 2019

GenMark Diagnostics to Participate in Upcoming Investor Conferences

GlobeNewswire November 13, 2019

GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019

GlobeNewswire October 23, 2019

GenMark Diagnostics Reports Second Quarter 2019 Results

GlobeNewswire August 5, 2019

GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference

GlobeNewswire July 25, 2019

GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019

GlobeNewswire July 22, 2019

GenMark Diagnostics to Participate in Upcoming Investor Conferences

GlobeNewswire May 23, 2019

GenMark Diagnostics to Present at the Bank of America Merrill Lynch Health Care Conference

GlobeNewswire May 1, 2019

GenMark Diagnostics Reports First Quarter 2019 Results

GlobeNewswire April 30, 2019